Revisiting rates of reactivation tuberculosis: a population-based approach
- PMID: 20395560
- PMCID: PMC2921602
- DOI: 10.1164/rccm.200909-1355OC
Revisiting rates of reactivation tuberculosis: a population-based approach
Abstract
Rationale: Reactivation tuberculosis (TB) occurs as a result of reactivation of latent TB infection (LTBI), and was reported to occur in the United States at a rate of 0.10 to 0.16 cases per 100 person-years in the 1950s; it has not been measured since.
Objectives: To calculate the rate of reactivation TB in a U.S. community.
Methods: A population-based tuberculin skin test survey for LTBI was performed in western Palm Beach County, Florida, from 1998 to 2000 along with a cluster analysis of TB case isolates in the same area from 1997 to 2001. Reactivation (unclustered) TB was presumed to have arisen from the population with LTBI.
Measurements and main results: The rate of reactivation TB among persons with LTBI without HIV infection was 0.040 cases per 100 person-years (95% confidence interval [CI], 0.024-0.067) using the n method and 0.058 cases per 100 person-years (95% CI, 0.038-0.089) using the n-1 method. HIV infection was the strongest risk factor for reactivation (rate ratio [RR], 57; 95% CI, 27-120; P < 0.001). Among persons without HIV infection, reactivation was increased among those older than 50 years (RR, 3.8; 95% CI, 1.3-11) and among those born in the United States (RR, 3.2; 95% CI, 1.1-9.3).
Conclusions: Rates of reactivation TB in this area have declined substantially since the 1950s. The greatest part of this decline may be attributed to the disappearance of old, healed TB in the population. If similar declines are seen in other areas of the United States, the cost-effectiveness of screening and treatment of LTBI may be substantially less than previously estimated.
Similar articles
-
Racial disparities in primary and reactivation tuberculosis in a rural community in the southeastern United States.Int J Tuberc Lung Dis. 2010 Jun;14(6):733-40. Int J Tuberc Lung Dis. 2010. PMID: 20487612 Clinical Trial.
-
State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.PLoS One. 2021 Apr 1;16(4):e0249012. doi: 10.1371/journal.pone.0249012. eCollection 2021. PLoS One. 2021. PMID: 33793612 Free PMC article.
-
Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.Am J Epidemiol. 2014 Jan 15;179(2):216-25. doi: 10.1093/aje/kwt246. Epub 2013 Oct 18. Am J Epidemiol. 2014. PMID: 24142915 Free PMC article.
-
Treatment of latent tuberculosis infection in HIV infected persons.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000171. doi: 10.1002/14651858.CD000171.pub3. Cochrane Database Syst Rev. 2010. PMID: 20091503 Free PMC article. Review.
-
[Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection].Ugeskr Laeger. 1997 Feb 24;159(9):1233-8. Ugeskr Laeger. 1997. PMID: 9072866 Review. Danish.
Cited by
-
Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States.Epidemiology. 2024 Mar 1;35(2):164-173. doi: 10.1097/EDE.0000000000001707. Epub 2023 Jan 30. Epidemiology. 2024. PMID: 38290139
-
TB-free Ebeye: Results from integrated TB and noncommunicable disease case finding in Ebeye, Marshall Islands.J Clin Tuberc Other Mycobact Dis. 2024 Feb 3;35:100418. doi: 10.1016/j.jctube.2024.100418. eCollection 2024 May. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 38356926 Free PMC article.
-
The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach.BMC Med. 2020 Jul 20;18(1):163. doi: 10.1186/s12916-020-01651-5. BMC Med. 2020. PMID: 32684164 Free PMC article.
-
The impact of active case finding on transmission dynamics of tuberculosis: A modelling study.PLoS One. 2021 Nov 19;16(11):e0257242. doi: 10.1371/journal.pone.0257242. eCollection 2021. PLoS One. 2021. PMID: 34797864 Free PMC article.
-
Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):552-8. doi: 10.1097/QAI.0000000000000219. J Acquir Immune Defic Syndr. 2014. PMID: 24853308 Free PMC article. Clinical Trial.
References
-
- Pratt R, Robison V, Navin T. Trends in Tuberculosis – United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:245–250. - PubMed
-
- Horsburgh CR, Moore M, Castro KG. Epidemiology of tuberculosis in the United States. In: Rom WN, Garay SM, editors. Tuberculosis, 2nd ed. Philadelphia PA: Lippincott Williams and Wilkins; 2004. pp. 31–45.
-
- Horsburgh CR. Prioritizing treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:260–267. - PubMed
-
- American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005;172:1169–1227. - PubMed
-
- Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703–1709. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical